Shili Wu
- Molecular Biology top 5%
- Physiology top 2%
- Surgery top 5%
- Computational Theory and Mathematics top 1%
- Pharmacology top 2%
- Co-authors
- Xinli LinGerald KoelschJordan TangAzar DashtiYong ZhuArnold von EckardsteinGerd AssmannHans R. Schöler
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers)Lipoproteins and Cardiovascular Health (4 papers)Cholesterol and Lipid Metabolism (4 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Shili Wu
30 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 2.2k
- Physiology 1.2k
- Surgery 693
- Computational Theory and Mathematics 518
- Pharmacology 488
Countries citing papers authored by Shili Wu
This map shows the geographic impact of Shili Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shili Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shili Wu more than expected).
Fields of papers citing papers by Shili Wu
This network shows the impact of papers produced by Shili Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shili Wu. The network helps show where Shili Wu may publish in the future.
Co-authorship network of co-authors of Shili Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Shili Wu. A scholar is included among the top collaborators of Shili Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shili Wu. Shili Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 9 | |
| 6 | 11 | |
| 7 | 27 | |
| 8 | 22 | |
| 9 | 31 | |
| 10 | 17 | |
| 11 | 8 | |
| 12 | 91 | |
| 13 | 15 | |
| 14 | 14 | |
| 15 | 12 | |
| 16 | 3 | |
| 17 | 22 | |
| 18 | 144 | |
| 19 | 52 | |
| 20 | 22 |
About Shili Wu
Shili Wu is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Biological Psychiatry, having authored 34 papers that have together received 3.5k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Lipoproteins and Cardiovascular Health (4 papers) and Cholesterol and Lipid Metabolism (4 papers). The work is most often cited by research in Physiology (1.2k citations), Computational Theory and Mathematics (518 citations) and Molecular Biology (2.2k citations). Shili Wu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Xinli Lin, Gerald Koelsch, Jordan Tang, Azar Dashti, Yong Zhu, Arnold von Eckardstein, Gerd Assmann, Hans R. Schöler, Jin Young Joo and Saiyong Zhu. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.